LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,157
تعداد مقالات10,573
تعداد مشاهده مقاله45,916,287
تعداد دریافت فایل اصل مقاله11,583,805
Amirhakimi, G.H., Talei, A.. (1394). Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone. سامانه مدیریت نشریات علمی, 29(1), 45-46.
G.H. Amirhakimi; A. Talei. "Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone". سامانه مدیریت نشریات علمی, 29, 1, 1394, 45-46.
Amirhakimi, G.H., Talei, A.. (1394). 'Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone', سامانه مدیریت نشریات علمی, 29(1), pp. 45-46.
Amirhakimi, G.H., Talei, A.. Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone. سامانه مدیریت نشریات علمی, 1394; 29(1): 45-46.

Papillary Carcinoma of Thyroid Gland in a Patient Treated with Recombinant Growth Hormone

Iranian Journal of Medical Sciences
مقاله 11، دوره 29، شماره 1، دی 2004، صفحه 45-46    اصل مقاله (31.75 K)
نوع مقاله: Case Report(s)
نویسندگان
G.H. Amirhakimi* 1؛ A. Talei2
1Endocrine and Metabolism Research Center, Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Surgery, Shiraz Uni-versity of Medical Sciences, Shiraz, Iran
چکیده
The first successful treatment of growth hormone (GH) deficient children with GH extracted from human pituitary was introduced during late 1950's.  The subsequent availability and use of recombinant GH (rhGH) for different clinical conditions raised the question of whether this new therapeutic modality increases the risk of certain conditions such as leukemia or malignancy.  Herein, we report on a 22-year-old man who was diagnosed as a case of GH deficiency at the age of 11 years, was treated with rhGH for 6 years and who developed papillary carcinoma of the thyroid gland 6 years after cessation of the treatment. 
آمار
تعداد مشاهده مقاله: 1,937
تعداد دریافت فایل اصل مقاله: 940


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب